Literature DB >> 6689700

[3H]5-Hydroxytryptamine binding sites: species and tissue variation.

R G Schnellmann, S J Waters, D L Nelson.   

Abstract

The characteristics of spiperone inhibition of [3H]5-hydroxytryptamine [(3H]5-HT; [3H]serotonin) binding were examined in dorsal (DH) and ventral (VH) hippocampus, corpus striatum (CS) or caudate nucleus (CN), and frontal cortex (FC) in the rabbit, guinea pig, and cat. Some of the properties of spiperone inhibition of [3H]5-HT binding in these species were similar to the properties previously found in the rat. Spiperone was significantly more potent in DH, VH, and FC than in CS or CN. It produced shallow or biphasic inhibition curves, resulting in Hill slopes of less than 1.0. Nonlinear regression analysis of the data showed that the inhibition curves fit a two-site binding model significantly better than a one-site model in each brain region. The dissociation constants of spiperone for the high-affinity binding site (KH) for all the tissues and species, except cat FC and rabbit DH, were very close to those previously found in the rat (2-13 nM). However, the dissociation constants for the low-affinity binding site (KL) were different from those in the rat in all species and tissues examined, except cat FC and CS. The present data are consistent with the concept of multiple 5-HT1 binding sites and suggest the presence of at least two, and perhaps as many as three, groups of sites in the mammalian brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6689700     DOI: 10.1111/j.1471-4159.1984.tb09699.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Antidepressant-like activity of 5-HT1A agonists measured with the forced swim test.

Authors:  S Wieland; I Lucki
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors.

Authors:  D K Lim; Z J Yu; B Hoskins; R W Rockhold; I K Ho
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

3.  5-Hydroxytryptamine 5-HT1B and 5-HT1D receptors mediating inhibition of adenylate cyclase activity. Pharmacological comparison with special reference to the effects of yohimbine, rauwolscine and some beta-adrenoceptor antagonists.

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-09       Impact factor: 3.000

4.  Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens.

Authors:  S M Mittman; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.

Authors:  M D Hall; H Gozlan; M B Emerit; S el Mestikawy; L Pichat; M Hamon
Journal:  Neurochem Res       Date:  1986-06       Impact factor: 3.996

6.  5.HT1 receptors in the vertebrate brain. Regional distribution examined by autoradiography.

Authors:  C Waeber; M M Dietl; D Hoyer; J M Palacios
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-11       Impact factor: 3.000

7.  Characterization of functional responses in A9 cells transfected with cloned rat 5-HT1C receptors.

Authors:  H W Boddeke; B J Hoffman; J M Palacios; H Knot; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

8.  Interaction of arylpiperazines with 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors: do discriminatory 5-HT1B receptor ligands exist?

Authors:  P Schoeffter; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

9.  Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.

Authors:  C A Marsden; K F Martin
Journal:  Br J Pharmacol       Date:  1986-10       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.